Skip to main content
. 2020 Apr 18;5(3):522–541. doi: 10.1016/j.bioactmat.2020.04.003

Table 3.

Multifunction of the PDA-modified nanoparticle drug carrier working as a drug system.

Function of the drug system Contributing portion Classes of the portion Representative agents Reference
Targeting Nanoparticle Nanoparticle Fe3O4 nanoparticles [54]
Loading “drug” Ligand RGD peptides [48]
Antibodies [105,106]
Folic acid [37,48,65,107,108]
TPP [54]
Imaging Nanoparticle Nanoparticle Au nanostructure [50]
Loading “drug” Radionuclide 125I [48]
Metal ion Cu2+ [50]
Mn2+ [63]
Bi2Se3 [69]
Fluorochrome Cy5-SE [109]
Photosensitizer Indocyanine green [32]
Chemical treatment (CT) Nanoparticle Nanoparticle Au nanostructure [82]
Loading “drug” Chemotherapeutics DOX [54,56,69,74,96,99]
Cisplatin [48,53]
Metal ion Cu2+ [50]
Ag+ [70,76,78,109]
Antibiotic Daptomycin [105]
Doxycycline [44]
Gas molecular NO [52]
Protein Lysozyme [57]
Photodynamic therapy (PDT) Loading “drug” Photosensitizer Ce6 [56]
Organic compound Methylene blue [102]
Photothermal therapy (PTT) Nanoparticle Nanoparticle Au nanostructure [109,110]
Nanosheet Black phosphorus [111]
Loading “drug” Organic compound 2-phenylethynesulfonamide [112]
PDA modification Organic compound PDA [82,105,110]
Immunotherapy Loading “drug” Antigen HbsAg [83]
Ligand CpG [66,83]
Gene therapy Loading “drug” Nucleic acid small interfering RNA [84,111]
hairpin DNA [68]
Bone regeneration Nanoparticle Nanoparticle HAp [82,113]
Loading “drug” Protein BMP-2 [94,114]
PDA modification Organic compound PDA [44]
Anti-inflammatory/Antioxidant Loading “drug” Glucocorticoid DEX [59]
Flavonoids Tanshinone IIA [93]
Hesperetin [115]
PDA modification Organic compound PDA [[116], [117], [118]]

DEX, Dexamethasone sodium phosphate; O, Nitric oxide; ICG, indocyanine green.